Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Venous oxygen saturation decreased; Infarct myocardial; Distress respiratory; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA), regulatory authority number FR-AFSSAPS-PC20210362. A 95-year-old female patient received bnt162b2 (COMIRNATY, Batch/Lot Number: EJ6795/EK9788), dose 2 intramuscular on 17Feb2021 (at the age of 95years) as single dose for Covid-19 immunization. The patient received the first dose of Comirnaty on an unspecified date for Covid-19 immunization (prophylactic vaccination). Medical history included hypertension arterial, bedridden, ischemic heart disease, renal failure; all from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylate lysine (KARDEGIC); amiodarone hydrochloride (CORDARONE), paroxetine, levothyroxine sodium (LEVOTHYROX), and esomeprazole; all taken for an unspecified indication, start and stop date were not reported. On 18Feb2021 (the day after vaccination), the patient experienced sudden respiratory distress in nursery home 80% desaturation. Call of the emergency aid services: major congestion, draft, crackles; ECG: shift D2-D3-VF mirror in D1, VL. Put on oxygen and brought to the emergency room. The patient had a posterior myocardial infarction and respiratory distress leading to death before arrival to the emergency room. The patient died on 18Feb2021. It was unknown if an autopsy was performed.; Reported Cause(s) of Death: Infarct myocardial; respiratory distress; Venous oxygen saturation decreased
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166